nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroflumethiazide—hypertension—type 2 diabetes mellitus	0.736	1	CtDrD
Hydroflumethiazide—KCNMA1—artery—type 2 diabetes mellitus	0.00237	0.0634	CbGeAlD
Hydroflumethiazide—CA1—nerve—type 2 diabetes mellitus	0.00179	0.0478	CbGeAlD
Hydroflumethiazide—CA9—islet of Langerhans—type 2 diabetes mellitus	0.00148	0.0395	CbGeAlD
Hydroflumethiazide—CA4—nerve—type 2 diabetes mellitus	0.0014	0.0374	CbGeAlD
Hydroflumethiazide—SLC12A3—nephron tubule—type 2 diabetes mellitus	0.00133	0.0355	CbGeAlD
Hydroflumethiazide—CA7—kidney—type 2 diabetes mellitus	0.00119	0.0318	CbGeAlD
Hydroflumethiazide—SLC12A3—kidney—type 2 diabetes mellitus	0.00117	0.0312	CbGeAlD
Hydroflumethiazide—KCNMA1—islet of Langerhans—type 2 diabetes mellitus	0.00114	0.0305	CbGeAlD
Hydroflumethiazide—SLC12A3—cortex of kidney—type 2 diabetes mellitus	0.00114	0.0304	CbGeAlD
Hydroflumethiazide—SLC12A1—nephron tubule—type 2 diabetes mellitus	0.00101	0.0271	CbGeAlD
Hydroflumethiazide—KCNMA1—retina—type 2 diabetes mellitus	0.000974	0.0261	CbGeAlD
Hydroflumethiazide—SLC12A1—kidney—type 2 diabetes mellitus	0.00089	0.0238	CbGeAlD
Hydroflumethiazide—SLC12A1—cortex of kidney—type 2 diabetes mellitus	0.000867	0.0232	CbGeAlD
Hydroflumethiazide—KCNMA1—cardiovascular system—type 2 diabetes mellitus	0.000824	0.022	CbGeAlD
Hydroflumethiazide—KCNMA1—pancreas—type 2 diabetes mellitus	0.000801	0.0214	CbGeAlD
Hydroflumethiazide—CA12—kidney—type 2 diabetes mellitus	0.000773	0.0207	CbGeAlD
Hydroflumethiazide—ATP1A1—islet of Langerhans—type 2 diabetes mellitus	0.000732	0.0196	CbGeAlD
Hydroflumethiazide—KCNMA1—adipose tissue—type 2 diabetes mellitus	0.000727	0.0194	CbGeAlD
Hydroflumethiazide—CA5B—cardiovascular system—type 2 diabetes mellitus	0.000709	0.019	CbGeAlD
Hydroflumethiazide—CA5B—pancreas—type 2 diabetes mellitus	0.000689	0.0184	CbGeAlD
Hydroflumethiazide—CA4—islet of Langerhans—type 2 diabetes mellitus	0.000676	0.0181	CbGeAlD
Hydroflumethiazide—CA14—liver—type 2 diabetes mellitus	0.000626	0.0168	CbGeAlD
Hydroflumethiazide—CA1—cardiovascular system—type 2 diabetes mellitus	0.000626	0.0167	CbGeAlD
Hydroflumethiazide—ATP1A1—retina—type 2 diabetes mellitus	0.000626	0.0167	CbGeAlD
Hydroflumethiazide—CA5B—adipose tissue—type 2 diabetes mellitus	0.000625	0.0167	CbGeAlD
Hydroflumethiazide—CA1—kidney—type 2 diabetes mellitus	0.000612	0.0164	CbGeAlD
Hydroflumethiazide—CA1—pancreas—type 2 diabetes mellitus	0.000608	0.0163	CbGeAlD
Hydroflumethiazide—ATP1A1—nephron tubule—type 2 diabetes mellitus	0.000589	0.0158	CbGeAlD
Hydroflumethiazide—CA2—islet of Langerhans—type 2 diabetes mellitus	0.000561	0.015	CbGeAlD
Hydroflumethiazide—CA1—adipose tissue—type 2 diabetes mellitus	0.000552	0.0148	CbGeAlD
Hydroflumethiazide—CA4—nephron tubule—type 2 diabetes mellitus	0.000545	0.0146	CbGeAlD
Hydroflumethiazide—ATP1A1—cardiovascular system—type 2 diabetes mellitus	0.000529	0.0142	CbGeAlD
Hydroflumethiazide—ATP1A1—kidney—type 2 diabetes mellitus	0.000518	0.0139	CbGeAlD
Hydroflumethiazide—ATP1A1—pancreas—type 2 diabetes mellitus	0.000514	0.0138	CbGeAlD
Hydroflumethiazide—KCNMA1—liver—type 2 diabetes mellitus	0.00051	0.0136	CbGeAlD
Hydroflumethiazide—ATP1A1—cortex of kidney—type 2 diabetes mellitus	0.000504	0.0135	CbGeAlD
Hydroflumethiazide—CA4—cardiovascular system—type 2 diabetes mellitus	0.000489	0.0131	CbGeAlD
Hydroflumethiazide—CA2—retina—type 2 diabetes mellitus	0.000479	0.0128	CbGeAlD
Hydroflumethiazide—CA4—kidney—type 2 diabetes mellitus	0.000479	0.0128	CbGeAlD
Hydroflumethiazide—ATP1A1—adipose tissue—type 2 diabetes mellitus	0.000467	0.0125	CbGeAlD
Hydroflumethiazide—CA4—cortex of kidney—type 2 diabetes mellitus	0.000466	0.0125	CbGeAlD
Hydroflumethiazide—CA2—nephron tubule—type 2 diabetes mellitus	0.000452	0.0121	CbGeAlD
Hydroflumethiazide—CA4—adipose tissue—type 2 diabetes mellitus	0.000431	0.0115	CbGeAlD
Hydroflumethiazide—CA2—cardiovascular system—type 2 diabetes mellitus	0.000406	0.0109	CbGeAlD
Hydroflumethiazide—CA2—kidney—type 2 diabetes mellitus	0.000397	0.0106	CbGeAlD
Hydroflumethiazide—CA2—pancreas—type 2 diabetes mellitus	0.000394	0.0105	CbGeAlD
Hydroflumethiazide—CA1—liver—type 2 diabetes mellitus	0.000387	0.0104	CbGeAlD
Hydroflumethiazide—CA2—cortex of kidney—type 2 diabetes mellitus	0.000386	0.0103	CbGeAlD
Hydroflumethiazide—CA2—adipose tissue—type 2 diabetes mellitus	0.000358	0.00957	CbGeAlD
Hydroflumethiazide—Orthostatic hypotension—Irbesartan—type 2 diabetes mellitus	0.000336	0.0022	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Gliclazide—type 2 diabetes mellitus	0.000335	0.00219	CcSEcCtD
Hydroflumethiazide—Asthenia—Nateglinide—type 2 diabetes mellitus	0.000332	0.00217	CcSEcCtD
Hydroflumethiazide—Vascular purpura—Ramipril—type 2 diabetes mellitus	0.000331	0.00217	CcSEcCtD
Hydroflumethiazide—Cramp muscle—Irbesartan—type 2 diabetes mellitus	0.000331	0.00217	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Metformin—type 2 diabetes mellitus	0.00033	0.00216	CcSEcCtD
Hydroflumethiazide—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.00033	0.00216	CcSEcCtD
Hydroflumethiazide—Dizziness—Tolazamide—type 2 diabetes mellitus	0.00033	0.00216	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Bromocriptine—type 2 diabetes mellitus	0.000328	0.00215	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Acarbose—type 2 diabetes mellitus	0.000328	0.00215	CcSEcCtD
Hydroflumethiazide—ATP1A1—liver—type 2 diabetes mellitus	0.000327	0.00876	CbGeAlD
Hydroflumethiazide—Nausea—Tolbutamide—type 2 diabetes mellitus	0.000326	0.00213	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Glipizide—type 2 diabetes mellitus	0.000324	0.00212	CcSEcCtD
Hydroflumethiazide—Constipation—Rosiglitazone—type 2 diabetes mellitus	0.000323	0.00212	CcSEcCtD
Hydroflumethiazide—Urticaria—Repaglinide—type 2 diabetes mellitus	0.000318	0.00208	CcSEcCtD
Hydroflumethiazide—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.000317	0.00208	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Nateglinide—type 2 diabetes mellitus	0.000316	0.00207	CcSEcCtD
Hydroflumethiazide—Orthostatic hypotension—Losartan—type 2 diabetes mellitus	0.000316	0.00207	CcSEcCtD
Hydroflumethiazide—Anorexia—Glipizide—type 2 diabetes mellitus	0.000316	0.00206	CcSEcCtD
Hydroflumethiazide—Rash—Chlorpropamide—type 2 diabetes mellitus	0.000315	0.00206	CcSEcCtD
Hydroflumethiazide—Rash—Tolazamide—type 2 diabetes mellitus	0.000315	0.00206	CcSEcCtD
Hydroflumethiazide—Agitation—Bromocriptine—type 2 diabetes mellitus	0.000314	0.00205	CcSEcCtD
Hydroflumethiazide—Headache—Tolazamide—type 2 diabetes mellitus	0.000313	0.00205	CcSEcCtD
Hydroflumethiazide—Headache—Chlorpropamide—type 2 diabetes mellitus	0.000313	0.00205	CcSEcCtD
Hydroflumethiazide—Cramp muscle—Losartan—type 2 diabetes mellitus	0.000311	0.00204	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Irbesartan—type 2 diabetes mellitus	0.000311	0.00204	CcSEcCtD
Hydroflumethiazide—Rash—Linagliptin—type 2 diabetes mellitus	0.000311	0.00204	CcSEcCtD
Hydroflumethiazide—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.000311	0.00204	CcSEcCtD
Hydroflumethiazide—Headache—Linagliptin—type 2 diabetes mellitus	0.000309	0.00202	CcSEcCtD
Hydroflumethiazide—Purpura—Ramipril—type 2 diabetes mellitus	0.000308	0.00201	CcSEcCtD
Hydroflumethiazide—Vertigo—Bromocriptine—type 2 diabetes mellitus	0.000307	0.00201	CcSEcCtD
Hydroflumethiazide—Dizziness—Nateglinide—type 2 diabetes mellitus	0.000306	0.002	CcSEcCtD
Hydroflumethiazide—Vomiting—Acarbose—type 2 diabetes mellitus	0.000305	0.00199	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Glimepiride—type 2 diabetes mellitus	0.000302	0.00198	CcSEcCtD
Hydroflumethiazide—Rash—Acarbose—type 2 diabetes mellitus	0.000302	0.00198	CcSEcCtD
Hydroflumethiazide—Dermatitis—Acarbose—type 2 diabetes mellitus	0.000302	0.00198	CcSEcCtD
Hydroflumethiazide—Urticaria—Rosiglitazone—type 2 diabetes mellitus	0.0003	0.00197	CcSEcCtD
Hydroflumethiazide—Nausea—Tolazamide—type 2 diabetes mellitus	0.000296	0.00194	CcSEcCtD
Hydroflumethiazide—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000296	0.00194	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.000295	0.00193	CcSEcCtD
Hydroflumethiazide—Anorexia—Glimepiride—type 2 diabetes mellitus	0.000294	0.00193	CcSEcCtD
Hydroflumethiazide—Vomiting—Nateglinide—type 2 diabetes mellitus	0.000294	0.00192	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Losartan—type 2 diabetes mellitus	0.000293	0.00192	CcSEcCtD
Hydroflumethiazide—Rash—Nateglinide—type 2 diabetes mellitus	0.000291	0.00191	CcSEcCtD
Hydroflumethiazide—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.000291	0.00191	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Irbesartan—type 2 diabetes mellitus	0.00029	0.0019	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Glipizide—type 2 diabetes mellitus	0.000288	0.00188	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Irbesartan—type 2 diabetes mellitus	0.000286	0.00187	CcSEcCtD
Hydroflumethiazide—Nausea—Acarbose—type 2 diabetes mellitus	0.000285	0.00186	CcSEcCtD
Hydroflumethiazide—Constipation—Glipizide—type 2 diabetes mellitus	0.000283	0.00185	CcSEcCtD
Hydroflumethiazide—Leukopenia—Glyburide—type 2 diabetes mellitus	0.000279	0.00183	CcSEcCtD
Hydroflumethiazide—Jaundice—Irbesartan—type 2 diabetes mellitus	0.000276	0.00181	CcSEcCtD
Hydroflumethiazide—Nausea—Nateglinide—type 2 diabetes mellitus	0.000275	0.0018	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000274	0.00179	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Losartan—type 2 diabetes mellitus	0.000273	0.00179	CcSEcCtD
Hydroflumethiazide—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.000271	0.00178	CcSEcCtD
Hydroflumethiazide—Orthostatic hypotension—Ramipril—type 2 diabetes mellitus	0.000271	0.00177	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Losartan—type 2 diabetes mellitus	0.00027	0.00176	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Glimepiride—type 2 diabetes mellitus	0.000269	0.00176	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Sitagliptin—type 2 diabetes mellitus	0.000268	0.00175	CcSEcCtD
Hydroflumethiazide—Cramp muscle—Ramipril—type 2 diabetes mellitus	0.000267	0.00175	CcSEcCtD
Hydroflumethiazide—Anorexia—Bromocriptine—type 2 diabetes mellitus	0.000266	0.00174	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Irbesartan—type 2 diabetes mellitus	0.000264	0.00173	CcSEcCtD
Hydroflumethiazide—Constipation—Sitagliptin—type 2 diabetes mellitus	0.000263	0.00172	CcSEcCtD
Hydroflumethiazide—Urticaria—Glipizide—type 2 diabetes mellitus	0.000263	0.00172	CcSEcCtD
Hydroflumethiazide—Jaundice—Losartan—type 2 diabetes mellitus	0.00026	0.0017	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000259	0.00169	CcSEcCtD
Hydroflumethiazide—Agitation—Gliclazide—type 2 diabetes mellitus	0.000258	0.00169	CcSEcCtD
Hydroflumethiazide—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000254	0.00166	CcSEcCtD
Hydroflumethiazide—Rash—Repaglinide—type 2 diabetes mellitus	0.000252	0.00165	CcSEcCtD
Hydroflumethiazide—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000252	0.00165	CcSEcCtD
Hydroflumethiazide—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000252	0.00165	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Ramipril—type 2 diabetes mellitus	0.000251	0.00164	CcSEcCtD
Hydroflumethiazide—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.000251	0.00164	CcSEcCtD
Hydroflumethiazide—CA2—liver—type 2 diabetes mellitus	0.000251	0.00671	CbGeAlD
Hydroflumethiazide—Headache—Repaglinide—type 2 diabetes mellitus	0.000251	0.00164	CcSEcCtD
Hydroflumethiazide—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.00025	0.00164	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.000249	0.00163	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Losartan—type 2 diabetes mellitus	0.000249	0.00163	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Valsartan—type 2 diabetes mellitus	0.000248	0.00162	CcSEcCtD
Hydroflumethiazide—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000245	0.00161	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Orlistat—type 2 diabetes mellitus	0.000245	0.0016	CcSEcCtD
Hydroflumethiazide—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000245	0.0016	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000244	0.0016	CcSEcCtD
Hydroflumethiazide—Anorexia—Glyburide—type 2 diabetes mellitus	0.000243	0.00159	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000242	0.00159	CcSEcCtD
Hydroflumethiazide—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000238	0.00156	CcSEcCtD
Hydroflumethiazide—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000238	0.00156	CcSEcCtD
Hydroflumethiazide—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000238	0.00156	CcSEcCtD
Hydroflumethiazide—Nausea—Repaglinide—type 2 diabetes mellitus	0.000238	0.00156	CcSEcCtD
Hydroflumethiazide—Asthenia—Glipizide—type 2 diabetes mellitus	0.000237	0.00155	CcSEcCtD
Hydroflumethiazide—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000237	0.00155	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Ramipril—type 2 diabetes mellitus	0.000234	0.00153	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000234	0.00153	CcSEcCtD
Hydroflumethiazide—Vertigo—Valsartan—type 2 diabetes mellitus	0.000231	0.00151	CcSEcCtD
Hydroflumethiazide—Vertigo—Orlistat—type 2 diabetes mellitus	0.000229	0.0015	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000228	0.00149	CcSEcCtD
Hydroflumethiazide—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000228	0.00149	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000227	0.00148	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000226	0.00148	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Metformin—type 2 diabetes mellitus	0.000225	0.00148	CcSEcCtD
Hydroflumethiazide—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000225	0.00147	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000224	0.00147	CcSEcCtD
Hydroflumethiazide—Jaundice—Ramipril—type 2 diabetes mellitus	0.000223	0.00146	CcSEcCtD
Hydroflumethiazide—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000222	0.00145	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000221	0.00145	CcSEcCtD
Hydroflumethiazide—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000221	0.00145	CcSEcCtD
Hydroflumethiazide—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000221	0.00145	CcSEcCtD
Hydroflumethiazide—Dizziness—Glipizide—type 2 diabetes mellitus	0.000219	0.00143	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000217	0.00142	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000213	0.0014	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000213	0.00139	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000211	0.00138	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000211	0.00138	CcSEcCtD
Hydroflumethiazide—Vomiting—Glipizide—type 2 diabetes mellitus	0.00021	0.00138	CcSEcCtD
Hydroflumethiazide—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.00021	0.00137	CcSEcCtD
Hydroflumethiazide—Rash—Glipizide—type 2 diabetes mellitus	0.000209	0.00137	CcSEcCtD
Hydroflumethiazide—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000209	0.00136	CcSEcCtD
Hydroflumethiazide—Headache—Glipizide—type 2 diabetes mellitus	0.000207	0.00136	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000206	0.00135	CcSEcCtD
Hydroflumethiazide—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000204	0.00134	CcSEcCtD
Hydroflumethiazide—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000204	0.00133	CcSEcCtD
Hydroflumethiazide—Agitation—Irbesartan—type 2 diabetes mellitus	0.000203	0.00133	CcSEcCtD
Hydroflumethiazide—Urticaria—Glyburide—type 2 diabetes mellitus	0.000202	0.00132	CcSEcCtD
Hydroflumethiazide—Anorexia—Valsartan—type 2 diabetes mellitus	0.0002	0.00131	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Losartan—type 2 diabetes mellitus	0.0002	0.00131	CcSEcCtD
Hydroflumethiazide—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.0002	0.00131	CcSEcCtD
Hydroflumethiazide—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000199	0.0013	CcSEcCtD
Hydroflumethiazide—Headache—Pioglitazone—type 2 diabetes mellitus	0.000199	0.0013	CcSEcCtD
Hydroflumethiazide—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000198	0.0013	CcSEcCtD
Hydroflumethiazide—Nausea—Glipizide—type 2 diabetes mellitus	0.000197	0.00129	CcSEcCtD
Hydroflumethiazide—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000196	0.00129	CcSEcCtD
Hydroflumethiazide—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000196	0.00128	CcSEcCtD
Hydroflumethiazide—Constipation—Gliclazide—type 2 diabetes mellitus	0.000196	0.00128	CcSEcCtD
Hydroflumethiazide—Rash—Glimepiride—type 2 diabetes mellitus	0.000195	0.00127	CcSEcCtD
Hydroflumethiazide—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000195	0.00127	CcSEcCtD
Hydroflumethiazide—Rash—Sitagliptin—type 2 diabetes mellitus	0.000194	0.00127	CcSEcCtD
Hydroflumethiazide—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000194	0.00127	CcSEcCtD
Hydroflumethiazide—Headache—Glimepiride—type 2 diabetes mellitus	0.000194	0.00127	CcSEcCtD
Hydroflumethiazide—Headache—Sitagliptin—type 2 diabetes mellitus	0.000193	0.00126	CcSEcCtD
Hydroflumethiazide—Agitation—Losartan—type 2 diabetes mellitus	0.000191	0.00125	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000191	0.00125	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000188	0.00123	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000187	0.00123	CcSEcCtD
Hydroflumethiazide—Vertigo—Losartan—type 2 diabetes mellitus	0.000187	0.00122	CcSEcCtD
Hydroflumethiazide—Leukopenia—Losartan—type 2 diabetes mellitus	0.000186	0.00122	CcSEcCtD
Hydroflumethiazide—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000184	0.00121	CcSEcCtD
Hydroflumethiazide—Nausea—Glimepiride—type 2 diabetes mellitus	0.000183	0.0012	CcSEcCtD
Hydroflumethiazide—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000183	0.0012	CcSEcCtD
Hydroflumethiazide—Asthenia—Glyburide—type 2 diabetes mellitus	0.000183	0.0012	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000183	0.0012	CcSEcCtD
Hydroflumethiazide—Anorexia—Metformin—type 2 diabetes mellitus	0.000182	0.00119	CcSEcCtD
Hydroflumethiazide—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000182	0.00119	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000181	0.00118	CcSEcCtD
Hydroflumethiazide—Constipation—Valsartan—type 2 diabetes mellitus	0.00018	0.00118	CcSEcCtD
Hydroflumethiazide—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000177	0.00116	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000177	0.00116	CcSEcCtD
Hydroflumethiazide—Rash—Bromocriptine—type 2 diabetes mellitus	0.000176	0.00115	CcSEcCtD
Hydroflumethiazide—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000176	0.00115	CcSEcCtD
Hydroflumethiazide—Headache—Bromocriptine—type 2 diabetes mellitus	0.000175	0.00114	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000174	0.00114	CcSEcCtD
Hydroflumethiazide—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000172	0.00113	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000172	0.00112	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000169	0.0011	CcSEcCtD
Hydroflumethiazide—Urticaria—Valsartan—type 2 diabetes mellitus	0.000167	0.00109	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000166	0.00109	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000166	0.00109	CcSEcCtD
Hydroflumethiazide—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000166	0.00108	CcSEcCtD
Hydroflumethiazide—Urticaria—Orlistat—type 2 diabetes mellitus	0.000165	0.00108	CcSEcCtD
Hydroflumethiazide—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000164	0.00107	CcSEcCtD
Hydroflumethiazide—Agitation—Ramipril—type 2 diabetes mellitus	0.000164	0.00107	CcSEcCtD
Hydroflumethiazide—Constipation—Metformin—type 2 diabetes mellitus	0.000164	0.00107	CcSEcCtD
Hydroflumethiazide—Anorexia—Losartan—type 2 diabetes mellitus	0.000162	0.00106	CcSEcCtD
Hydroflumethiazide—Vomiting—Glyburide—type 2 diabetes mellitus	0.000162	0.00106	CcSEcCtD
Hydroflumethiazide—Rash—Glyburide—type 2 diabetes mellitus	0.000161	0.00105	CcSEcCtD
Hydroflumethiazide—Dermatitis—Glyburide—type 2 diabetes mellitus	0.00016	0.00105	CcSEcCtD
Hydroflumethiazide—Vertigo—Ramipril—type 2 diabetes mellitus	0.00016	0.00105	CcSEcCtD
Hydroflumethiazide—Leukopenia—Ramipril—type 2 diabetes mellitus	0.00016	0.00105	CcSEcCtD
Hydroflumethiazide—Headache—Glyburide—type 2 diabetes mellitus	0.00016	0.00104	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000157	0.00103	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000157	0.00102	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000155	0.00101	CcSEcCtD
Hydroflumethiazide—Constipation—Irbesartan—type 2 diabetes mellitus	0.000154	0.00101	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000153	0.001	CcSEcCtD
Hydroflumethiazide—Urticaria—Metformin—type 2 diabetes mellitus	0.000152	0.000995	CcSEcCtD
Hydroflumethiazide—Nausea—Glyburide—type 2 diabetes mellitus	0.000151	0.00099	CcSEcCtD
Hydroflumethiazide—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000151	0.00099	CcSEcCtD
Hydroflumethiazide—Asthenia—Valsartan—type 2 diabetes mellitus	0.000151	0.000987	CcSEcCtD
Hydroflumethiazide—Asthenia—Orlistat—type 2 diabetes mellitus	0.000149	0.000975	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000148	0.000967	CcSEcCtD
Hydroflumethiazide—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000145	0.000952	CcSEcCtD
Hydroflumethiazide—Constipation—Losartan—type 2 diabetes mellitus	0.000145	0.000951	CcSEcCtD
Hydroflumethiazide—Rash—Gliclazide—type 2 diabetes mellitus	0.000144	0.000944	CcSEcCtD
Hydroflumethiazide—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000144	0.000943	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000144	0.000941	CcSEcCtD
Hydroflumethiazide—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000143	0.000939	CcSEcCtD
Hydroflumethiazide—Headache—Gliclazide—type 2 diabetes mellitus	0.000143	0.000938	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000143	0.000934	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000142	0.00093	CcSEcCtD
Hydroflumethiazide—Dizziness—Valsartan—type 2 diabetes mellitus	0.000139	0.000909	CcSEcCtD
Hydroflumethiazide—Anorexia—Ramipril—type 2 diabetes mellitus	0.000139	0.000909	CcSEcCtD
Hydroflumethiazide—Dizziness—Orlistat—type 2 diabetes mellitus	0.000137	0.000899	CcSEcCtD
Hydroflumethiazide—Asthenia—Metformin—type 2 diabetes mellitus	0.000137	0.000899	CcSEcCtD
Hydroflumethiazide—Nausea—Gliclazide—type 2 diabetes mellitus	0.000136	0.000889	CcSEcCtD
Hydroflumethiazide—Urticaria—Losartan—type 2 diabetes mellitus	0.000135	0.000884	CcSEcCtD
Hydroflumethiazide—Vomiting—Valsartan—type 2 diabetes mellitus	0.000134	0.000874	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000133	0.000871	CcSEcCtD
Hydroflumethiazide—Rash—Valsartan—type 2 diabetes mellitus	0.000133	0.000867	CcSEcCtD
Hydroflumethiazide—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000132	0.000866	CcSEcCtD
Hydroflumethiazide—Vomiting—Orlistat—type 2 diabetes mellitus	0.000132	0.000864	CcSEcCtD
Hydroflumethiazide—Headache—Valsartan—type 2 diabetes mellitus	0.000132	0.000862	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000131	0.000857	CcSEcCtD
Hydroflumethiazide—Rash—Orlistat—type 2 diabetes mellitus	0.000131	0.000857	CcSEcCtD
Hydroflumethiazide—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000131	0.000856	CcSEcCtD
Hydroflumethiazide—Headache—Orlistat—type 2 diabetes mellitus	0.00013	0.000851	CcSEcCtD
Hydroflumethiazide—Asthenia—Irbesartan—type 2 diabetes mellitus	0.00013	0.000848	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000127	0.000829	CcSEcCtD
Hydroflumethiazide—Dizziness—Metformin—type 2 diabetes mellitus	0.000127	0.000828	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000125	0.000819	CcSEcCtD
Hydroflumethiazide—Nausea—Valsartan—type 2 diabetes mellitus	0.000125	0.000817	CcSEcCtD
Hydroflumethiazide—Constipation—Ramipril—type 2 diabetes mellitus	0.000125	0.000816	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000124	0.000809	CcSEcCtD
Hydroflumethiazide—Nausea—Orlistat—type 2 diabetes mellitus	0.000123	0.000807	CcSEcCtD
Hydroflumethiazide—Asthenia—Losartan—type 2 diabetes mellitus	0.000122	0.000798	CcSEcCtD
Hydroflumethiazide—Vomiting—Metformin—type 2 diabetes mellitus	0.000122	0.000796	CcSEcCtD
Hydroflumethiazide—Rash—Metformin—type 2 diabetes mellitus	0.000121	0.00079	CcSEcCtD
Hydroflumethiazide—Dermatitis—Metformin—type 2 diabetes mellitus	0.000121	0.000789	CcSEcCtD
Hydroflumethiazide—Headache—Metformin—type 2 diabetes mellitus	0.00012	0.000785	CcSEcCtD
Hydroflumethiazide—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000119	0.000782	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000116	0.000761	CcSEcCtD
Hydroflumethiazide—Urticaria—Ramipril—type 2 diabetes mellitus	0.000116	0.000758	CcSEcCtD
Hydroflumethiazide—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000115	0.000751	CcSEcCtD
Hydroflumethiazide—Rash—Irbesartan—type 2 diabetes mellitus	0.000114	0.000745	CcSEcCtD
Hydroflumethiazide—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000114	0.000744	CcSEcCtD
Hydroflumethiazide—Nausea—Metformin—type 2 diabetes mellitus	0.000114	0.000744	CcSEcCtD
Hydroflumethiazide—Headache—Irbesartan—type 2 diabetes mellitus	0.000113	0.00074	CcSEcCtD
Hydroflumethiazide—Dizziness—Losartan—type 2 diabetes mellitus	0.000112	0.000735	CcSEcCtD
Hydroflumethiazide—Vomiting—Losartan—type 2 diabetes mellitus	0.000108	0.000707	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000107	0.000703	CcSEcCtD
Hydroflumethiazide—Nausea—Irbesartan—type 2 diabetes mellitus	0.000107	0.000702	CcSEcCtD
Hydroflumethiazide—Rash—Losartan—type 2 diabetes mellitus	0.000107	0.000701	CcSEcCtD
Hydroflumethiazide—Dermatitis—Losartan—type 2 diabetes mellitus	0.000107	0.000701	CcSEcCtD
Hydroflumethiazide—Headache—Losartan—type 2 diabetes mellitus	0.000106	0.000697	CcSEcCtD
Hydroflumethiazide—Asthenia—Ramipril—type 2 diabetes mellitus	0.000105	0.000684	CcSEcCtD
Hydroflumethiazide—Nausea—Losartan—type 2 diabetes mellitus	0.000101	0.000661	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Ramipril—type 2 diabetes mellitus	9.97e-05	0.000653	CcSEcCtD
Hydroflumethiazide—Dizziness—Ramipril—type 2 diabetes mellitus	9.64e-05	0.000631	CcSEcCtD
Hydroflumethiazide—Vomiting—Ramipril—type 2 diabetes mellitus	9.27e-05	0.000606	CcSEcCtD
Hydroflumethiazide—Rash—Ramipril—type 2 diabetes mellitus	9.19e-05	0.000601	CcSEcCtD
Hydroflumethiazide—Dermatitis—Ramipril—type 2 diabetes mellitus	9.18e-05	0.000601	CcSEcCtD
Hydroflumethiazide—Headache—Ramipril—type 2 diabetes mellitus	9.13e-05	0.000597	CcSEcCtD
Hydroflumethiazide—Nausea—Ramipril—type 2 diabetes mellitus	8.66e-05	0.000566	CcSEcCtD
Hydroflumethiazide—CA7—Metabolism—GNB3—type 2 diabetes mellitus	2.35e-05	0.000321	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—GNB3—type 2 diabetes mellitus	2.35e-05	0.000321	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.35e-05	0.000321	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GLP1R—type 2 diabetes mellitus	2.35e-05	0.00032	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—HMOX1—type 2 diabetes mellitus	2.34e-05	0.000319	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—HMOX1—type 2 diabetes mellitus	2.34e-05	0.000319	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—SLC9A1—type 2 diabetes mellitus	2.33e-05	0.000317	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PSMD6—type 2 diabetes mellitus	2.33e-05	0.000317	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—SNAP25—type 2 diabetes mellitus	2.33e-05	0.000317	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—SREBF1—type 2 diabetes mellitus	2.33e-05	0.000317	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—CAT—type 2 diabetes mellitus	2.31e-05	0.000315	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—CAT—type 2 diabetes mellitus	2.31e-05	0.000315	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—ADCY5—type 2 diabetes mellitus	2.31e-05	0.000314	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CETP—type 2 diabetes mellitus	2.3e-05	0.000313	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—GPX1—type 2 diabetes mellitus	2.3e-05	0.000313	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CTGF—type 2 diabetes mellitus	2.28e-05	0.000311	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—HMGCR—type 2 diabetes mellitus	2.26e-05	0.000308	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—APOB—type 2 diabetes mellitus	2.25e-05	0.000306	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—APOB—type 2 diabetes mellitus	2.25e-05	0.000306	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—CD36—type 2 diabetes mellitus	2.24e-05	0.000305	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—SNAP25—type 2 diabetes mellitus	2.23e-05	0.000304	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PSMD6—type 2 diabetes mellitus	2.23e-05	0.000304	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—SREBF1—type 2 diabetes mellitus	2.23e-05	0.000304	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—ADRA2A—type 2 diabetes mellitus	2.22e-05	0.000302	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PPP2CA—type 2 diabetes mellitus	2.21e-05	0.000301	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—SLC2A2—type 2 diabetes mellitus	2.2e-05	0.000299	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CTGF—type 2 diabetes mellitus	2.19e-05	0.000298	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—GSTM1—type 2 diabetes mellitus	2.18e-05	0.000297	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—GSTM1—type 2 diabetes mellitus	2.18e-05	0.000297	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.18e-05	0.000297	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—GNB3—type 2 diabetes mellitus	2.18e-05	0.000297	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—HMOX1—type 2 diabetes mellitus	2.17e-05	0.000296	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—HMGCR—type 2 diabetes mellitus	2.17e-05	0.000296	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CPT1A—type 2 diabetes mellitus	2.15e-05	0.000293	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—MTR—type 2 diabetes mellitus	2.15e-05	0.000293	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—LPL—type 2 diabetes mellitus	2.14e-05	0.000292	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—LPL—type 2 diabetes mellitus	2.14e-05	0.000292	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—CAT—type 2 diabetes mellitus	2.14e-05	0.000292	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PSMD6—type 2 diabetes mellitus	2.14e-05	0.000291	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—SNAP25—type 2 diabetes mellitus	2.14e-05	0.000291	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—SREBF1—type 2 diabetes mellitus	2.14e-05	0.000291	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.13e-05	0.00029	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—ADRA2A—type 2 diabetes mellitus	2.12e-05	0.000289	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—MTHFR—type 2 diabetes mellitus	2.12e-05	0.000289	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—NAMPT—type 2 diabetes mellitus	2.11e-05	0.000287	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CYP1A2—type 2 diabetes mellitus	2.11e-05	0.000287	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—SLC2A1—type 2 diabetes mellitus	2.11e-05	0.000287	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CTGF—type 2 diabetes mellitus	2.1e-05	0.000286	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—ADCY5—type 2 diabetes mellitus	2.1e-05	0.000286	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—ADCY5—type 2 diabetes mellitus	2.1e-05	0.000286	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—LIPC—type 2 diabetes mellitus	2.1e-05	0.000286	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GCK—type 2 diabetes mellitus	2.1e-05	0.000286	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—HBA1—type 2 diabetes mellitus	2.1e-05	0.000286	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—GPX1—type 2 diabetes mellitus	2.09e-05	0.000285	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—GPX1—type 2 diabetes mellitus	2.09e-05	0.000285	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CYP11A1—type 2 diabetes mellitus	2.08e-05	0.000284	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PPARA—type 2 diabetes mellitus	2.08e-05	0.000283	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—HMGCR—type 2 diabetes mellitus	2.08e-05	0.000283	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—APOB—type 2 diabetes mellitus	2.08e-05	0.000283	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CYP3A4—type 2 diabetes mellitus	2.05e-05	0.00028	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—SLC9A1—type 2 diabetes mellitus	2.05e-05	0.000279	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CYP2E1—type 2 diabetes mellitus	2.04e-05	0.000278	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ADRA2A—type 2 diabetes mellitus	2.04e-05	0.000277	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—CD36—type 2 diabetes mellitus	2.04e-05	0.000277	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—CD36—type 2 diabetes mellitus	2.04e-05	0.000277	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CETP—type 2 diabetes mellitus	2.02e-05	0.000276	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—GSTM1—type 2 diabetes mellitus	2.02e-05	0.000276	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.02e-05	0.000275	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—GCG—type 2 diabetes mellitus	2.02e-05	0.000275	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CYP1A2—type 2 diabetes mellitus	2.02e-05	0.000275	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—SLC2A1—type 2 diabetes mellitus	2.02e-05	0.000275	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—AGT—type 2 diabetes mellitus	2.02e-05	0.000275	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PPP2CA—type 2 diabetes mellitus	2.01e-05	0.000274	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PPP2CA—type 2 diabetes mellitus	2.01e-05	0.000274	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—SRC—type 2 diabetes mellitus	1.99e-05	0.000272	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—LPL—type 2 diabetes mellitus	1.99e-05	0.00027	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—CALM1—type 2 diabetes mellitus	1.98e-05	0.00027	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—APOE—type 2 diabetes mellitus	1.98e-05	0.000269	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CYP3A4—type 2 diabetes mellitus	1.97e-05	0.000268	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CYP2E1—type 2 diabetes mellitus	1.96e-05	0.000267	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—APOA1—type 2 diabetes mellitus	1.95e-05	0.000266	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—ADCY5—type 2 diabetes mellitus	1.94e-05	0.000265	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—VEGFA—type 2 diabetes mellitus	1.94e-05	0.000264	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—GPX1—type 2 diabetes mellitus	1.94e-05	0.000264	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CYP1A2—type 2 diabetes mellitus	1.93e-05	0.000264	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—GCG—type 2 diabetes mellitus	1.93e-05	0.000264	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—SLC2A1—type 2 diabetes mellitus	1.93e-05	0.000264	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—SLC2A4—type 2 diabetes mellitus	1.93e-05	0.000264	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—MTHFR—type 2 diabetes mellitus	1.93e-05	0.000263	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—MTHFR—type 2 diabetes mellitus	1.93e-05	0.000263	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PPARA—type 2 diabetes mellitus	1.89e-05	0.000258	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PPARA—type 2 diabetes mellitus	1.89e-05	0.000258	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—CD36—type 2 diabetes mellitus	1.89e-05	0.000257	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CYP3A4—type 2 diabetes mellitus	1.89e-05	0.000257	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—SNAP25—type 2 diabetes mellitus	1.88e-05	0.000256	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PSMD6—type 2 diabetes mellitus	1.88e-05	0.000256	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—SREBF1—type 2 diabetes mellitus	1.88e-05	0.000256	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PPP2CA—type 2 diabetes mellitus	1.86e-05	0.000254	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—GCG—type 2 diabetes mellitus	1.86e-05	0.000253	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—SLC2A4—type 2 diabetes mellitus	1.86e-05	0.000253	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CTGF—type 2 diabetes mellitus	1.85e-05	0.000251	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—AGT—type 2 diabetes mellitus	1.83e-05	0.00025	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—AGT—type 2 diabetes mellitus	1.83e-05	0.00025	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—HMGCR—type 2 diabetes mellitus	1.83e-05	0.000249	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—CALM1—type 2 diabetes mellitus	1.8e-05	0.000246	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—CALM1—type 2 diabetes mellitus	1.8e-05	0.000246	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—APOE—type 2 diabetes mellitus	1.8e-05	0.000245	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—APOE—type 2 diabetes mellitus	1.8e-05	0.000245	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ADRA2A—type 2 diabetes mellitus	1.79e-05	0.000244	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—MTHFR—type 2 diabetes mellitus	1.79e-05	0.000244	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—TGFB1—type 2 diabetes mellitus	1.78e-05	0.000243	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—APOA1—type 2 diabetes mellitus	1.78e-05	0.000242	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—APOA1—type 2 diabetes mellitus	1.78e-05	0.000242	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PPARA—type 2 diabetes mellitus	1.75e-05	0.000239	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.74e-05	0.000237	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—GNB3—type 2 diabetes mellitus	1.74e-05	0.000237	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—HMOX1—type 2 diabetes mellitus	1.73e-05	0.000236	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CYP2E1—type 2 diabetes mellitus	1.72e-05	0.000234	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PPARG—type 2 diabetes mellitus	1.72e-05	0.000234	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CAT—type 2 diabetes mellitus	1.71e-05	0.000233	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—SLC2A1—type 2 diabetes mellitus	1.7e-05	0.000232	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CYP1A2—type 2 diabetes mellitus	1.7e-05	0.000232	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—AGT—type 2 diabetes mellitus	1.7e-05	0.000231	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—INS—type 2 diabetes mellitus	1.69e-05	0.00023	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—CALM1—type 2 diabetes mellitus	1.67e-05	0.000228	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—GNB3—type 2 diabetes mellitus	1.67e-05	0.000227	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.67e-05	0.000227	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—APOE—type 2 diabetes mellitus	1.66e-05	0.000227	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—IL6—type 2 diabetes mellitus	1.66e-05	0.000226	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—HMOX1—type 2 diabetes mellitus	1.66e-05	0.000226	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CYP3A4—type 2 diabetes mellitus	1.66e-05	0.000226	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—APOB—type 2 diabetes mellitus	1.66e-05	0.000226	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—APOA1—type 2 diabetes mellitus	1.65e-05	0.000224	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CAT—type 2 diabetes mellitus	1.64e-05	0.000223	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GCG—type 2 diabetes mellitus	1.63e-05	0.000222	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—SLC2A4—type 2 diabetes mellitus	1.63e-05	0.000222	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—GSTM1—type 2 diabetes mellitus	1.61e-05	0.00022	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.6e-05	0.000218	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—GNB3—type 2 diabetes mellitus	1.6e-05	0.000218	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—HMOX1—type 2 diabetes mellitus	1.59e-05	0.000217	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—APOB—type 2 diabetes mellitus	1.59e-05	0.000217	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—LPL—type 2 diabetes mellitus	1.58e-05	0.000216	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CAT—type 2 diabetes mellitus	1.57e-05	0.000214	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PPARG—type 2 diabetes mellitus	1.57e-05	0.000213	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PPARG—type 2 diabetes mellitus	1.57e-05	0.000213	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—ADCY5—type 2 diabetes mellitus	1.55e-05	0.000211	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—GSTM1—type 2 diabetes mellitus	1.55e-05	0.000211	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—ALB—type 2 diabetes mellitus	1.55e-05	0.000211	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—GPX1—type 2 diabetes mellitus	1.55e-05	0.00021	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—INS—type 2 diabetes mellitus	1.54e-05	0.000209	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—INS—type 2 diabetes mellitus	1.54e-05	0.000209	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—APOB—type 2 diabetes mellitus	1.52e-05	0.000208	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—LPL—type 2 diabetes mellitus	1.52e-05	0.000207	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CD36—type 2 diabetes mellitus	1.5e-05	0.000205	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—ADCY5—type 2 diabetes mellitus	1.49e-05	0.000202	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.49e-05	0.000202	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—GSTM1—type 2 diabetes mellitus	1.48e-05	0.000202	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—GPX1—type 2 diabetes mellitus	1.48e-05	0.000202	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PIK3R1—type 2 diabetes mellitus	1.48e-05	0.000202	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—NOS3—type 2 diabetes mellitus	1.48e-05	0.000202	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—LPL—type 2 diabetes mellitus	1.46e-05	0.000198	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PPARG—type 2 diabetes mellitus	1.45e-05	0.000197	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CD36—type 2 diabetes mellitus	1.44e-05	0.000196	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—MTHFR—type 2 diabetes mellitus	1.43e-05	0.000194	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ADCY5—type 2 diabetes mellitus	1.43e-05	0.000194	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.42e-05	0.000194	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—INS—type 2 diabetes mellitus	1.42e-05	0.000194	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—GPX1—type 2 diabetes mellitus	1.42e-05	0.000193	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—ALB—type 2 diabetes mellitus	1.41e-05	0.000192	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—ALB—type 2 diabetes mellitus	1.41e-05	0.000192	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.41e-05	0.000191	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GNB3—type 2 diabetes mellitus	1.41e-05	0.000191	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—HMOX1—type 2 diabetes mellitus	1.4e-05	0.000191	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PPARA—type 2 diabetes mellitus	1.4e-05	0.000191	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CD36—type 2 diabetes mellitus	1.38e-05	0.000188	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CAT—type 2 diabetes mellitus	1.38e-05	0.000188	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—MTHFR—type 2 diabetes mellitus	1.37e-05	0.000186	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.37e-05	0.000186	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—AGT—type 2 diabetes mellitus	1.35e-05	0.000185	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PTGS2—type 2 diabetes mellitus	1.35e-05	0.000184	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—NOS3—type 2 diabetes mellitus	1.35e-05	0.000183	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PIK3R1—type 2 diabetes mellitus	1.35e-05	0.000183	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—NOS3—type 2 diabetes mellitus	1.35e-05	0.000183	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PIK3R1—type 2 diabetes mellitus	1.35e-05	0.000183	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PPARA—type 2 diabetes mellitus	1.34e-05	0.000183	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—APOB—type 2 diabetes mellitus	1.34e-05	0.000183	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CALM1—type 2 diabetes mellitus	1.33e-05	0.000181	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—APOE—type 2 diabetes mellitus	1.33e-05	0.000181	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—APOA1—type 2 diabetes mellitus	1.31e-05	0.000179	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—MTHFR—type 2 diabetes mellitus	1.31e-05	0.000178	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GSTM1—type 2 diabetes mellitus	1.3e-05	0.000178	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—ALB—type 2 diabetes mellitus	1.3e-05	0.000178	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—AGT—type 2 diabetes mellitus	1.3e-05	0.000177	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PPARA—type 2 diabetes mellitus	1.29e-05	0.000175	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—LPL—type 2 diabetes mellitus	1.28e-05	0.000174	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CALM1—type 2 diabetes mellitus	1.28e-05	0.000174	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—APOE—type 2 diabetes mellitus	1.27e-05	0.000173	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—APOA1—type 2 diabetes mellitus	1.26e-05	0.000171	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ADCY5—type 2 diabetes mellitus	1.25e-05	0.000171	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GPX1—type 2 diabetes mellitus	1.25e-05	0.00017	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PIK3R1—type 2 diabetes mellitus	1.25e-05	0.00017	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—NOS3—type 2 diabetes mellitus	1.25e-05	0.00017	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—AGT—type 2 diabetes mellitus	1.25e-05	0.00017	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—AKT1—type 2 diabetes mellitus	1.24e-05	0.000169	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PTGS2—type 2 diabetes mellitus	1.23e-05	0.000168	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PTGS2—type 2 diabetes mellitus	1.23e-05	0.000168	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CALM1—type 2 diabetes mellitus	1.22e-05	0.000167	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—APOE—type 2 diabetes mellitus	1.22e-05	0.000166	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CD36—type 2 diabetes mellitus	1.22e-05	0.000166	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—APOA1—type 2 diabetes mellitus	1.21e-05	0.000164	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PPP2CA—type 2 diabetes mellitus	1.2e-05	0.000164	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PPARG—type 2 diabetes mellitus	1.16e-05	0.000157	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—MTHFR—type 2 diabetes mellitus	1.15e-05	0.000157	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PTGS2—type 2 diabetes mellitus	1.14e-05	0.000155	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—INS—type 2 diabetes mellitus	1.13e-05	0.000154	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PPARA—type 2 diabetes mellitus	1.13e-05	0.000154	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PPARG—type 2 diabetes mellitus	1.11e-05	0.000151	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—AGT—type 2 diabetes mellitus	1.09e-05	0.000149	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—INS—type 2 diabetes mellitus	1.09e-05	0.000148	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CALM1—type 2 diabetes mellitus	1.08e-05	0.000147	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—APOE—type 2 diabetes mellitus	1.07e-05	0.000146	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PPARG—type 2 diabetes mellitus	1.06e-05	0.000145	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—APOA1—type 2 diabetes mellitus	1.06e-05	0.000144	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—INS—type 2 diabetes mellitus	1.04e-05	0.000142	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—ALB—type 2 diabetes mellitus	1.04e-05	0.000142	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—ALB—type 2 diabetes mellitus	9.97e-06	0.000136	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PIK3R1—type 2 diabetes mellitus	9.95e-06	0.000135	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—NOS3—type 2 diabetes mellitus	9.95e-06	0.000135	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ALB—type 2 diabetes mellitus	9.56e-06	0.00013	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PIK3R1—type 2 diabetes mellitus	9.53e-06	0.00013	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—NOS3—type 2 diabetes mellitus	9.53e-06	0.00013	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PPARG—type 2 diabetes mellitus	9.34e-06	0.000127	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—INS—type 2 diabetes mellitus	9.16e-06	0.000125	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PIK3R1—type 2 diabetes mellitus	9.14e-06	0.000124	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—NOS3—type 2 diabetes mellitus	9.14e-06	0.000124	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PTGS2—type 2 diabetes mellitus	9.1e-06	0.000124	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PTGS2—type 2 diabetes mellitus	8.72e-06	0.000119	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ALB—type 2 diabetes mellitus	8.4e-06	0.000114	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PTGS2—type 2 diabetes mellitus	8.36e-06	0.000114	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PIK3R1—type 2 diabetes mellitus	8.04e-06	0.000109	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—NOS3—type 2 diabetes mellitus	8.04e-06	0.000109	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PTGS2—type 2 diabetes mellitus	7.35e-06	0.0001	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—AKT1—type 2 diabetes mellitus	6.8e-06	9.26e-05	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—AKT1—type 2 diabetes mellitus	6.19e-06	8.43e-05	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—AKT1—type 2 diabetes mellitus	6.19e-06	8.43e-05	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—AKT1—type 2 diabetes mellitus	5.73e-06	7.81e-05	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—AKT1—type 2 diabetes mellitus	4.57e-06	6.23e-05	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—AKT1—type 2 diabetes mellitus	4.38e-06	5.97e-05	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—AKT1—type 2 diabetes mellitus	4.2e-06	5.72e-05	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—AKT1—type 2 diabetes mellitus	3.69e-06	5.03e-05	CbGpPWpGaD
